BullFrog AI Holdings, Inc. SEC filings BFRGW
BullFrog AI Holdings, Inc. has 205 filings in SEC EDGAR's recent list, going back to Oct 22, 2020. Its latest annual report, Form 10-K, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 20, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jun 10, 2026 | — |
| CORRESP | Letter to the SEC | Jun 8, 2026 | — |
| UPLOAD | Letter from the SEC | Jun 4, 2026 | — |
| EFFECT | Filing | Nov 25, 2025 | — |
| CORRESP | Letter to the SEC | Nov 24, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 24, 2025 | — |
| CORRESP | Letter to the SEC | Sep 17, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2025 | — |
| EFFECT | Filing | Nov 29, 2024 | — |
| CORRESP | Letter to the SEC | Nov 26, 2024 | — |
| CORRESP | Letter to the SEC | Nov 25, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 20, 2024 | — |
| EFFECT | Filing | Aug 21, 2024 | — |
| CORRESP | Letter to the SEC | Aug 19, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2024 | — |
| EFFECT | Filing | Jan 31, 2024 | — |
| CORRESP | Letter to the SEC | Jan 29, 2024 | — |
| CORRESP | Letter to the SEC | Jan 29, 2024 | — |
| CORRESP | Letter to the SEC | Jan 29, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 24, 2024 | — |
| DRS | Filing | Jan 19, 2024 | — |
| NT 10-Q | Filing | May 16, 2023 | Mar 31, 2023 |
| NT 10-K | Filing | Apr 3, 2023 | Dec 31, 2022 |
| CERT | Filing | Feb 14, 2023 | — |
| EFFECT | Filing | Feb 13, 2023 | — |
| CORRESP | Letter to the SEC | Feb 13, 2023 | — |
| CORRESP | Letter to the SEC | Feb 10, 2023 | — |
| CORRESP | Letter to the SEC | Feb 10, 2023 | — |
| CORRESP | Letter to the SEC | Feb 8, 2023 | — |
| CORRESP | Letter to the SEC | Feb 7, 2023 | — |
| CORRESP | Letter to the SEC | Feb 7, 2023 | — |
| CORRESP | Letter to the SEC | Feb 1, 2023 | — |
| CORRESP | Letter to the SEC | Feb 1, 2023 | — |
| CORRESP | Letter to the SEC | Jan 31, 2023 | — |
| 8-A12B | Filing | Jan 23, 2023 | — |
| CORRESP | Letter to the SEC | Jan 23, 2023 | — |
| CORRESP | Letter to the SEC | Jan 23, 2023 | — |
| CORRESP | Letter to the SEC | Jan 17, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 17, 2023 | — |
| CORRESP | Letter to the SEC | Dec 8, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 7, 2022 | — |
| CORRESP | Letter to the SEC | Nov 28, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 15, 2022 | — |
| CORRESP | Letter to the SEC | Nov 7, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 3, 2022 | — |
| CORRESP | Letter to the SEC | Oct 19, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 2, 2022 | — |
| DRSLTR | Filing | Aug 15, 2022 | — |
| DRS/A | Filing | Aug 15, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2022 | — |
| DRS | Filing | Jun 10, 2022 | — |
| D | Filing | May 12, 2022 | — |
| C/A | Filing | Dec 14, 2020 | — |
| C/A | Filing | Nov 27, 2020 | — |
| C/A | Filing | Oct 27, 2020 | — |
| C | Filing | Oct 22, 2020 | — |
Showing 56 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BFRG (Nasdaq), BFRGW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Gaithersburg, MD
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1829247
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.